Biotechnology | Diagnostics | HIV | Therapeutics | Vaccine | WHO
UNAIDS reported Fewest new HIV cases since late 1980s
On Nov. 26, 2024, the the United Nations reported that fewer people contracted HIV last year than at…
Patient with HIV achieved remission following stem cell transplant
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
Researchers documented third known case of HIV remission involving stem cell transplant
On Feb. 15, 2022, a woman with HIV who received a cord blood stem cell transplant to treat…
NIH researchers identified how two people controlled HIV after stopping treatment
On Oct. 29, 2021, research led by scientists at the National Institutes of Health announced they had identified…
Biotechnology | FDA | HIV | Therapeutics
U.S. FDA approved expanded indication of Gilead’s Biktarvy for Treatment of HIV-1 in pediatric populations
On Oct. 18, 2021, Gilead Sciences announced that the Food and Drug Administration had approved a new low-dose…
ViiV Healthcare analysis showed no antiretroviral therapy interruptions due to COVID-19
On Oct. 21, 2020, ViiV Healthcare, majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced…
Brain cells can harbor and spread HIV virus to the body
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
ImmunityBio announced durable virus control of SHIV without anti-retroviral therapy
On Mar. 10, 2020, ImmunityBio announced results from studies evaluating N-803, an IL-15 superagonist, alone and in combination…
The CDC reported newborn HIV infection reductions of 80% since 1981
On Jul. 9, 2002, the U.S. Centers for Disease Control and Prevention (CDC) reported newborn HIV infection reductions…
Human herpesvirus 8 (HHV-8), a causative agent for Kaposi’s sarcoma, was identified
In 1994, human herpesvirus 8 (HHV-8), a causative agent for Kaposi’s sarcoma (KS), was identified. HHV-8 is also…